Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Dave, Paresh ^a   Vadera, Bhavin ^b,g   Kumar, Ajay M V ^c   Chinnakali, Palanivel ^f   Modi, Bhavesh ^d   Solanki, Rajesh ^e   Patel, Pranav ^a   Patel, Prakash ^a   Pujara, Kirit ^a   Nimavat, Pankaj ^a   Shah, Amar ^b   Bharaswadkar, Sandeep ^b   Rade, Kiran ^b   Parmar, Malik ^b   Nair, Sreenivas Achuthan ^b  

^a GOVERNMENT OF INDIA   (India)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c South East Asia Regional Office   (India)

^d GMERS Medical College and Civil Hospital   (India)

^e B J MEDICAL COLLEGE   (India)

^f JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^g State Tuberculosis Training and Demonstration Centre Near Tuberculosis and Chest Department Civil Hospital Campus   (India)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE REGISTRY; DRUG SCREENING; DRUG SUSCEPTIBILITY TESTING; EARLY DIAGNOSIS; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH PROGRAM; HUMAN; INDIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; TUBERCULOSIS CONTROL; DRUG EFFECTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDIES; RIFAMPIN; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84929501368     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121996     Document Type: Article

References (32)

1. Central TB Division (2013) TB India 2013 Revised National TB Control Programme Annual Status Report. New Delhi, India.
2. Ramachandran R, Nalini S, Chandrasekar V, Dave PV, Sanghvi AS, Wares F, et al. (2009) Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. Int J Tuberc Lung Dis 13: 7. Available: http://www.ingentaconnect.com/content/iuatld/ijtld/2009/00000013/00000009/art00018?crawler=true. Accessed 3 October 2013.
3. World Health Organization (2009) Treatment of tuberculosis: guidelines. 4th Editio. Geneva, Switzerland.
4. STOP TB Partnership World Health Organization (2006) Global Plan to STOP TB 2006-2015. Geneva, Switzerland.
5. Central TB Division (2012) Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India. New Delhi, India.
6. Central TB Division (2011) Module 5 Programme Monitoring. Revised National TB Control Programme Training Course for Programme Manager (Module 5-9). New Delhi, India.
7. Central TB Division (2011) Module 3 Treatment Services. Revised National TB Control Programme Training Course for Programme Manager (Module 1-4). New Delhi, India.
8. State TB Cell Gujarat (2013) Revised National TB Control Programme Performance Report, Gujarat First Quarter 2013. Gandhinagar, India.
9. State TB Cell Gujarat (2014) Revised National TB Control Programme Performance Report, Gujarat Second Quarter, 2014. Gandhinagar, India.
10. State TB Cell Gujarat (2013) Revised National TB Control Programme Performance Report, Gujarat Third Quarter, 2013. Gandhinagar, India.
11. State TB Cell Gujarat (2014) Revised National TB Control Programme Performance Report, Gujarat First Quarter, 2014. Gandhinagar, India.
12. State TB Cell Gujarat (2013) Revised National TB Control Programme Peformance Report, Gujarat Second Quarter, 2013. Gandhinagar, India.
13. State TB Cell Gujarat (2013) Revised National TB Control Programme Performance Report, Gujarat Fourth Quarter, 2013. Gandhinagar, India.
14. Deepa D, Achanta S, Jaju J, Rao K, Samyukta R, Claassens M, et al. (2013) The impact of isoniazid resistance on the treatment outcomes of smear positive re-treatment tuberculosis patients in the state of Andhra Pradesh, India. PLOS One 8: e76189. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3795751&tool=pmcentrez&rendertype=abstract. Accessed 5 September 2014. doi: 10.1371/journal.pone.0076189 PMID: 24146839
15. Singla N, Satyanarayana S, Sachdeva KS, Van den Bergh R, Reid T, Tayler-Smith K, et al. (2014) Impact of Introducing the Line Probe Assay on Time to Treatment Initiation of MDR-TB in Delhi, India. PLOS One 9: e102989. Available: http://dx.plos.org/10.1371/journal.pone.0102989. Accessed 2 September 2014. doi: 10.1371/journal.pone.0102989 PMID: 25058124
16. Chadha SS, Sharath BN, Reddy K, Jaju J, Vishnu PH, Rao S, et al. (2011) Operational challenges in diagnosing multi-drug resistant TB and initiating treatment in Andhra Pradesh, India. PLOS One 6: e26659. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3206824&tool=pmcentrez&rendertype=abstract. Accessed 12 August 2014. doi: 10.1371/journal.pone.0026659 PMID: 22073182
17. Abeyunawardena SC, Sharath BN, Van den Bergh R, Naik B, Pallewatte N (2014) Management of previously treated tuberculosis patients in Kalutara district, Sri Lanka: how are we faring? Public Heal Action I: 105-109.
18. Qi W, Harries D, Hinderaker SG (2011) Performance of culture and drug susceptibility testing in pulmonary tuberculosis patients in northern China. Int J Tuberc Lung Dis 15: 137-139. Available: http://www.ncbi.nlm.nih.gov/pubmed/21276311. PMID: 21276311
19. Khann S, Mao ET, Rajendra YP, Satyanarayana S, Nagaraja SB, Kumar AM (2013) Linkage of presumptive multidrug resistant tuberculosis (MDR-TB) patients to diagnostic and treatment services in Cambodia. PLOS One 8: e59903. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3636254&tool=pmcentrez&rendertype=abstract. Accessed 1 September 2014. doi: 10.1371/journal.pone.0059903 PMID: 23634202
20. Kilale AM, Ngowi BJ, Mfi GS, Egwaga S, Doulla B, Kumar AMV, et al. (2013) Are sputum samples of retreatment tuberculosis reaching the reference laboratories? A 9-year audit in Tanzania. I: 156-159.
21. State TB Cell Gujarat (2013) TB Gujarat 2013 Revised National TB Control Programme Annual Status Report. Gandhinagar, India.
22. Central TB Division (2012) National Strategic Plan for Tuberculosis Control 2012-2017. New Delhi, India. doi: 10.1097/QAI.0b013e31825f313b PMID: 23186241
23. Espinal MA, Kim SJ, Suarez PG, Kam KM, Khomenko AG, Migloiri GB, et al. (2000) Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA 283: 2537-2545. Available: http://www.ncbi.nlm.nih.gov/pubmed/10815117. PMID: 10815117
24. Gegia M, Cohen T, Kalandadze I, Vashakidze L, Furin J (2012) Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009. Int J Tuberc Lung Dis 16: 812-816. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3786434&tool=pmcentrez&rendertype=abstract. doi: 10.5588/ijtld.11.0637 PMID: 22507372
25. Jacobson KR, Theron D, Victor TC, Streicher EM, Warren RM, Murray RB (2011) Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South Africa. Clin Infect Dis 53: 369-372. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3202325&tool=pmcentrez&rendertype=abstract. Accessed 13 August 2014. doi: 10.1093/cid/cir406 PMID: 21810750
26. Menzies D, Benedetti A, Paydar A, Royce S, Madhukar P, Burman W, et al. (2009) Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysis. PLOS Med 6: e1000150. Available: http://dx.plos.org/10.1371/journal.pmed.1000150. Accessed 30 August 2014. PMID: 20101802
27. Santha T, Thomas A, Chandrasekaran V, Selvakumar N, Gopi PG, Subramani R, et al. (2006) Initial drug susceptibility profile of M. tuberculosis among patients under TB programme in South India. Int J Tuberc Lung Dis. 10: 52-57. PMID: 16466037
28. Paramasivan CN, Bhaskarair K, Venkataraman P, Chandrasekaran V, Narayanan PR (2000) Surveillance of Drug Resistance In Tuberculosis In The State Of Tamil Nadu: Indian Journal of Tuberculosis. 2000; 47(1):27-33.
29. Furin J, Gegia M, Mitnick C, Rich M, Shin S, Becerra M, et al. (2012) Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experience. Bull World Health Organ 90: 63-66. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3260578&tool=pmcentrez&rendertype=abstract. Accessed 6 September 2014. doi: 10.2471/BLT.11.092320 PMID: 22271966
30. Vijay S, Balasangameshwara VH, Jagannatha PS, Saroja VN, Jagota P (2002) Re-Treatment Outcome Of Smear Positive.
31. Joseph P, Chandrasekaran V, Thomas A, Gopi PG, Rajeswari R, Balasubramanian R, et al. (2006) Influence Of Drug Susceptibility On Treatment Outcome And Susceptibility Profile Of "Failures" To Category Ii Regimen. Indian J Tuberc 2006; 53:141-148
32. Frieden TR, Brudney KF, Harries AD (2014) Global Tuberculosis Perspectives, Prospects, and Priorities. 30333. doi: 10.1001/jama.2014.11450.Conflict PMID: 25188638